Cash-strapped Zoono seeks A$2.1m from rights issue

Cash-strapped Zoono seeks A$2.1m from rights issue
Hand and surface sanitisers were in demand during the pandemic. (Image: Getty)
Denise McNabb
After continuing to burn cash and as its revenue plunges, Zoono Group plans to raise A$2.1 million (NZ$2.2m) through a pro-rata rights issue with free options to fund projects, a joint venture with Douglas Pharmaceuticals, China expansion and working capital. The Australian stock exchange-listed New Zealand manufacturer of antimicrobial hand and surface sanitisers announced the share offer in tandem with the release of its March 31 third-quarter report.The report details a dire future for the company unless it changes direction away from e...

More Markets

Low expectation for first carbon auction of the year
Markets

Low expectation for first carbon auction of the year

Carbon prices are too low compared to the auction floor.

Kiwi dollar faring better amid Trump’s trade war uncertainty
Economy

Kiwi dollar faring better amid Trump’s trade war uncertainty

Bank economists are starting to rejig their NZD forecasts higher. 

Spark's slide helps drive NZ sharemarket down
Markets Market Close

Spark's slide helps drive NZ sharemarket down

The S&P/NZX 50 Index closed at 12,166.14, down 100.11 points or 0.82%.

Graham Skellern 17 Mar 2025
Ebos shoots down pet food bid speculation
Markets

Ebos shoots down pet food bid speculation

Reports in the Australian are inaccurate, healthcare and animal care firm says.

Staff reporters 17 Mar 2025